Prime Medicine, Inc. (PRME) return on invested capital (ROIC)
Prime Medicine, Inc. (PRME) earned a return on invested capital of -276.1% in fiscal 2025 (the year ended December 31, 2025). That is 4292.6 percentage points higher than the -4568.7% of fiscal 2024. Figures as of 17 Nov 2026, 21:10 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Return on invested capital, fiscal 2025
- -276.1%
- Change on fiscal 2024
- +4292.6 pts
- Highest on record
- -180.2%fiscal 2022
- Lowest on record
- -4568.7%fiscal 2024
- Fiscal years on record
- 42022–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Prime Medicine, Inc. return on invested capital (ROIC), in more detail
Across the 4 fiscal years on record (2022–2025), the highest was -180.2% in fiscal 2022 and the lowest -4568.7% in fiscal 2024. The fiscal 2025 figure is higher than in 67% of the 3 earlier fiscal years on record, whose median is -603.5%.
Return on invested capital by fiscal year
Prime Medicine, Inc. return on invested capital (ROIC), year by year
| Fiscal year | Return on invested capital | Change | Year ended |
|---|---|---|---|
| 2025 | -276.1% | 4292.6 pts up | |
| 2024 | -4568.7% | 3965.1 pts down | |
| 2023 | -603.5% | 423.3 pts down | |
| 2022 | -180.2% | — |
Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.
How to read it
It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.
Prime Medicine, Inc., figure by figure
- Prime Medicine, Inc. market cap
- Prime Medicine, Inc. revenue
- Prime Medicine, Inc. earnings
- Prime Medicine, Inc. earnings per share (EPS)
- Prime Medicine, Inc. P/E ratio
- Prime Medicine, Inc. P/S ratio
- Prime Medicine, Inc. P/B ratio
- Prime Medicine, Inc. free cash flow
- Prime Medicine, Inc. operating margin
- Prime Medicine, Inc. dividend
- Prime Medicine, Inc. shares outstanding
- Prime Medicine, Inc. total debt
- Prime Medicine, Inc. cash on hand
- Prime Medicine, Inc. total assets
- Prime Medicine, Inc. return on equity (ROE)
Prime Medicine, Inc. (PRME) overview: price, valuation and scorecard
Prime Medicine, Inc. return on invested capital (ROIC): questions and answers
What is Prime Medicine, Inc.'s return on invested capital?
Prime Medicine, Inc. (PRME) earned a return on invested capital of -276.1% in fiscal 2025 (the year ended December 31, 2025). That is 4292.6 percentage points higher than the -4568.7% of fiscal 2024.
Is Prime Medicine, Inc.'s return on invested capital high or low compared with its own history?
The fiscal 2025 figure is higher than in 67% of the 3 earlier fiscal years on record, whose median is -603.5%.
What are the highest and lowest return on invested capital figures on record for Prime Medicine, Inc.?
Across the 4 fiscal years on record (2022–2025), the highest was -180.2% in fiscal 2022 and the lowest -4568.7% in fiscal 2024.
How is Prime Medicine, Inc.'s return on invested capital calculated?
Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.
Fiscal years are named for the calendar year they end in.
Learn: return on invested capital (ROIC)
All stocks guides →- Return on invested capital (ROIC) vs ROE and ROA
Return on invested capital (ROIC) is after-tax operating profit divided by the money tied up in the business: debt plus equity, less cash. A company earning $15 million after tax on $100 million of invested capital has a 15% ROIC. Unlike return on equity, it does not rise just because a company borrows more.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Prime Medicine, Inc. (PRME) return on invested capital (ROIC)”, data as of 17 November 2026. https://funkfolio.com/stock/PRME/roic
Underlying data: the company's filings with the SEC and Yahoo Finance.